SLN EPS Estimates
Silence Therapeutics plc
$8.68
-$0.67(-7.17%)
37
Overall
40
Value
36
Tech
36
Quality
Market Cap
$581.14M
Volume
1.13M
52W Range
$4.19 - $17.58
Target Price
$35.80
SLN EPS estimates: the consensus estimate for Silence Therapeutics plc's current fiscal year is -$1.03 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
SLN EPS Estimates
- EPS estimate, current quarter
- $-0.26
- EPS estimate, next quarter
- $-0.28
- EPS estimate, current year
- $-1.03
- EPS estimate, next year
- $-1.31
- EPS growth, 3-year
- -115.44%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.20 |
| 2024 | $-0.25 |
| 2024 | $0.57 |
| 2024 | $-0.02 |
| 2023 | $-0.39 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SLN | $8.68 | -7.2% | 1.13M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Silence Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW